Slide 1: Financial Results & Operational Update
FINANCIAL RESULTS & OPERATIONAL UPDATE Half year ended 31 December 2024 Kingsley Hall C h i e f E x e c u t iv e O f f i c e r 28 February 2025 Micro-X HY25 Results I 1
Slide 2: Important Notice
IMPORTANT NOTICE S C O P E & L I M I T A T I O N S This Presentation has been prepared by Micro-X Limited (Micro-X or the Company) (ASX.MX1). The Presentation is a summary only and does not contain all the information about the Company’s assets and liabilities, financial position and performance, pr
Slide 3: Creating Revolutionary X-Ray Imaging to Better Lives
CREATING REVOLUTIONARY X-RAY IMAGING TO BETTER LIVES Curious I Collaborative I Determine d Micro-X HY25 Results I 3
Slide 4: Overview
OVERVIEW Strategy reset supported by new non dilutive funding contracts and partners 1 Strategy reset to focus on Medical Imaging – Medical CT is the future of Micro-X and leverages key features of our proprietary NEX Technology 2 Funding gap narrowed & Balance Sheet strengthened – $0.7M operating c
Slide 5: FY25 Strategy Reset – Medical Focused
FY25 STRATEGY RESET – MEDICAL FOCUSED Narrowing our focus to drive execution with a focus on tangible outcomes 01 02 03 Focus Monetise Discontinue on Medical Imaging Security Division Argus Operations – Medical CT is the future of Micro-X – Execute on ongoing partnering negotiations – Material cost
Slide 6: World First Imaging Technology
WORLD FIRST IMAGING TECHNOLOGY Micro-X has created a world first technology platform that delivers transformative imaging solutions Micro-X proprietary CNT technology Lighter - Cold cathode emitter made of millions of nanotubes emits digitally controlled electrons Cold cathode - generates high quali
Slide 7: Focus on Medical Imaging
FOCUS ON MEDICAL IMAGING Smaller and smarter X-ray and CT enabled through Micro-X’s patented NEX Technology platform Medical Security MOBILE DIGITAL MEDICAL CHECKPOINTS & RADIOLOGY CT BAGGAGE CT SCANNER Lightweight and ultra-mobile x-ray Head CT – mobile out of hospital Baggage CT scanner for securi
Slide 8: Results & Highlights
RESULTS & HIGHLIGHTS Financial Half-year ended 31 December 2024 Micro-X HY25 Results | 7
Slide 9: Key Financials - 1H25
KEY FINANCIALS - 1H25 Increasing funded development services Total Revenue1 Contract Revenue $4.0M Impact of lumpy Rover sales - major $3.0M ASA & DHS development work2 tender opportunity underway (1H24 $8.2m) (1H24 $3.7m) Additional Income Contract Cash Receipts3 $3.4M FY25 Research and Development
Slide 10: Reduced Funding Gap
REDUCED FUNDING GAP Managing the cost base and increasing funded development services $0.7M $0.3M $18.6M Operating Cash outflows Reduced unfunded New Contracts Secured - Continuing Operations1 development costs2 for FY25 & FY26 Close to breakeven All major development funded with First $12.5 ARPA-H
Slide 11: Operational Achievements
OPERATIONAL ACHIEVEMENTS New commercialisation strategies delivering milestones US tender underway World first 3D CT images $6.1M DHS Contract Ext. Rover Plus advanced to final stage of Test bench and software produces high US Dept of Homeland Security for Airport evaluation with major US hospital g
Slide 12: Focused on Medical Imaging
FOCUSED ON MEDICAL IMAGING B u i l d i n g a b u s i n e s s n o t j u s t a t e c h n o l o g y
Slide 13: Advantages of Micro-X CT
ADVANTAGES OF MICRO-X CT Micro-X NEX technology offers major advantages over traditional CT US$7.4 billion global market with over 375 million CT images annually1,2 SIMPLER SYSTEM COST EFFECTIVE No rotating slip ring More cost effective system No oil cooling to build and install Simple CNT tubes Che
Slide 14: Delivered World First 3D Head CT Images
DELIVERED WORLD FIRST 3D HEAD CT IMAGES Preparing hospital systems for human clinical trials in 2025 to support approval for stroke detection Saving lives with stroke diagnosis in any ambulance → Mobile – 70kg unit suitable for all road and air ambulances → Accurate – 8 second scan for 3D imaging do
Slide 15: ARPA-H - Up to $25M Non-Dilutive Funding
ARPA-H - UP TO $25M NON-DILUTIVE FUNDING* Fully funds the development of Micro-X proprietary, portable, Full Body CT scanner Micro-X Inc. has signed a $25m development funding contract → Funding to design and deliver a lightweight, rugged, and portable CT scanner for integration into a “hospital on
Slide 16: Rover Plus Sales
ROVER PLUS SALES Targeting larger opportunities and establishing Medical CT sales channels Focus on Rover Plus sales to grow profitability & Medical CT sales channels → Rover Plus is no longer limited in technique range, it is one of the lowest cost high power mobile X-Ray carts in market, easy to u
Slide 17: Monetising Our Checkpoints & Security Business
MONETISING OUR CHECKPOINTS & SECURITY BUSINESS Realising value from fully funded development work with the US Department of Homeland Security Two Baggage Scanner prototypes – supporting TSA testing → Remainder of contract focused on developing deep learning algorithms to enhance the identification a
Slide 18: First Partnership Deal in Security for SE Asia
FIRST PARTNERSHIP DEAL IN SECURITY FOR SE ASIA $5.6m deal with Billion Prima - Specialist cargo and baggage scanner provider Strategy - $5.6m for monetising baggage scanner in SE ASIA with long term opportunity for supply of X-ray tubes and generators → $2.4m equity subscription and $3.2m developmen
Slide 19: Objectives & Milestones 2025
OBJECTIVES & MILESTONES 2025 Key near-term operational objectives Commercial products Products In Development Corporate & Financial Mobile DR Head CT & Full Body CT Corporate > Execute near term Rover Plus hospital tender > Commence Head CT imaging trials > Carefully manage financial resources → Com
Slide 20: Strengthened Balance Sheet
STRENGTHENED BALANCE SHEET Capital raising sized to bridge to cash flow stability $6.0m Raising + $5.6m Partnership $000 Key Outcomes Placement (7cps) 2,000 > $6.5M additional funding to be received in February 20251 Placement – completed 1,800 Placement – directors subject to EGM 200 > Contracted p
Slide 21: Wrap Up
WRAP UP Five key take aways – a leading medical imaging company 1 Focus on Medical Imaging – Medical CT is the future of Micro-X 2 Balance sheet strengthened - $6.5m cash to be received by 28 February 2025 – $6m Capital Raising & $5.6m Billion Prima strategic partnership 3 First Security Partnership
Slide 22: Appendices
APPENDICES FINANCIALS Micro-X HY25 Results I 22
Slide 23: Profit & Loss – 1H FY2025
PROFIT & LOSS – 1H FY2025 Key points → Product revenue In 1H24 revenues included large, non-recurring Rover orders from SAAB for JP2060 and the Aust Govt orders for Ukraine humanitarian efforts. Currently involved in a large tender with objective to target larger, ongoing revenue opportunities. → Co
Slide 24: Balance Sheet – December 2024
BALANCE SHEET – 31 DECEMBER 2024 Key points → Cash and Cash Equivalents at 31 December 2024, is prior to $6.0M Capital Raising and $5.6M Billion Prima partnership announced in February 2025. → Trade and Other Receivables includes $3.3M R&D receivable at 31 December 2024. → Inventories at 31 December